| Primary |
| Drug Use For Unknown Indication |
40.8% |
| Rheumatoid Arthritis |
23.9% |
| Systemic Lupus Erythematosus |
11.8% |
| Product Used For Unknown Indication |
5.4% |
| Arthritis |
2.1% |
| Sjogren's Syndrome |
1.8% |
| Hypertension |
1.5% |
| Pain |
1.4% |
| Connective Tissue Disorder |
1.2% |
| Depression |
1.2% |
| Cardiovascular Disorder |
1.1% |
| Cutaneous Lupus Erythematosus |
1.0% |
| Asthma |
0.9% |
| Lupus Syndrome |
0.9% |
| Joint Deposit |
0.9% |
| Spinal Column Stenosis |
0.9% |
| Arthralgia |
0.8% |
| Borrelia Infection |
0.8% |
| Polymyositis |
0.8% |
| Sarcoidosis |
0.8% |
|
| Vision Blurred |
9.6% |
| Visual Impairment |
8.1% |
| Drug Exposure During Pregnancy |
7.4% |
| Retinal Detachment |
7.4% |
| Weight Decreased |
7.4% |
| Cataract |
5.2% |
| Electrocardiogram Qt Prolonged |
5.2% |
| Macular Degeneration |
5.2% |
| Pruritus |
4.4% |
| Rash |
4.4% |
| Retinopathy |
4.4% |
| Vomiting |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Renal Failure Acute |
3.7% |
| Tremor |
3.7% |
| Depression |
3.0% |
| Dyspnoea |
3.0% |
| Gastrointestinal Haemorrhage |
3.0% |
| Pancreatitis |
3.0% |
| Presyncope |
3.0% |
|
| Secondary |
| Rheumatoid Arthritis |
25.2% |
| Product Used For Unknown Indication |
18.6% |
| Drug Use For Unknown Indication |
12.9% |
| Behcet's Syndrome |
8.9% |
| Systemic Lupus Erythematosus |
4.3% |
| Arthritis |
3.9% |
| Pain |
3.4% |
| Joint Swelling |
3.3% |
| Oedema Peripheral |
3.2% |
| Hypertension |
2.8% |
| Vasculitis |
2.0% |
| Depression |
1.9% |
| Prophylaxis |
1.6% |
| Asthma |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Dermatomyositis |
1.3% |
| Arthralgia |
1.1% |
| Sleep Disorder |
1.0% |
| Anxiety |
0.9% |
| Osteoporosis |
0.9% |
|
| Drug Hypersensitivity |
13.8% |
| Weight Decreased |
9.2% |
| Retinal Detachment |
8.2% |
| Vomiting |
7.1% |
| Vision Blurred |
6.1% |
| Drug Ineffective |
5.6% |
| Systemic Lupus Erythematosus |
5.6% |
| Squamous Cell Carcinoma Of Skin |
5.1% |
| Cataract |
4.6% |
| Weight Increased |
4.1% |
| Progressive Multifocal Leukoencephalopathy |
3.6% |
| Thrombocytopenia |
3.6% |
| Transient Ischaemic Attack |
3.6% |
| Bone Fissure |
3.1% |
| Hepatitis Fulminant |
3.1% |
| Retinopathy |
3.1% |
| Rheumatoid Arthritis |
3.1% |
| Chest Discomfort |
2.6% |
| Nausea |
2.6% |
| Oedema Peripheral |
2.6% |
|
| Concomitant |
| Rheumatoid Arthritis |
36.3% |
| Product Used For Unknown Indication |
27.0% |
| Drug Use For Unknown Indication |
8.0% |
| Systemic Lupus Erythematosus |
4.5% |
| Hypertension |
3.2% |
| Osteoporosis |
3.1% |
| Pain |
2.9% |
| Arthritis |
2.0% |
| Depression |
1.8% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Asthma |
1.4% |
| Psoriatic Arthropathy |
1.2% |
| Vitamin Supplementation |
1.1% |
| Fibromyalgia |
1.1% |
| Hypothyroidism |
1.0% |
| Anxiety |
0.8% |
| Prophylaxis |
0.8% |
| Insomnia |
0.8% |
| Diabetes Mellitus |
0.8% |
| Pulmonary Arterial Hypertension |
0.8% |
|
| Injection Site Pain |
15.6% |
| Rheumatoid Arthritis |
10.5% |
| Vomiting |
7.8% |
| Weight Decreased |
6.2% |
| Nausea |
5.1% |
| Sinusitis |
4.7% |
| Pain In Extremity |
4.7% |
| Weight Increased |
4.5% |
| Pain |
4.5% |
| Drug Ineffective |
3.9% |
| Pneumonia |
3.8% |
| Injection Site Swelling |
3.6% |
| Injection Site Reaction |
3.5% |
| Urinary Tract Infection |
3.5% |
| Pyrexia |
3.3% |
| Rash |
3.3% |
| Headache |
3.0% |
| Injection Site Irritation |
3.0% |
| Fatigue |
2.8% |
| Systemic Lupus Erythematosus |
2.8% |
|
| Interacting |
| Rheumatoid Arthritis |
17.4% |
| Pain |
13.0% |
| Drug Use For Unknown Indication |
8.7% |
| Systemic Lupus Erythematosus |
8.7% |
| Anxiety |
4.3% |
| Back Pain |
4.3% |
| Blood Pressure |
4.3% |
| Coagulopathy |
4.3% |
| Hypertension |
4.3% |
| Intervertebral Disc Protrusion |
4.3% |
| Lyme Disease |
4.3% |
| Nerve Injury |
4.3% |
| Neuralgia |
4.3% |
| Neuropathy Peripheral |
4.3% |
| Product Used For Unknown Indication |
4.3% |
| Rhinitis Allergic |
4.3% |
|
| Somnolence |
22.2% |
| Weight Decreased |
22.2% |
| Electrocardiogram Qt Prolonged |
11.1% |
| Feeling Abnormal |
11.1% |
| Headache |
11.1% |
| Nerve Injury |
11.1% |
| Sjogren's Syndrome |
11.1% |
|
